4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-038791
EVP, Research & CSO sold 14,920 shares at an average $44.64 ($666,058)
- EVP, Research & CSO acquired 14,920 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-06-23 | Option exercise | +5,560 | $1.53 | $8,507 | 5,560 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2020-06-23 | Sale | −5,560 | $38.99 | $216,778 | 0 | D: show line 2 in the form |
| Virgin Herbert EVP, Research & CSO | 2020-06-24 | Option exercise | +9,360 | $1.53 | $14,321 | 9,360 | D: show line 3 in the form |
| Virgin Herbert EVP, Research & CSO | 2020-06-24 | Sale | −9,360 | $48.00 | $449,280 | 0 | D: show line 4 in the form |
| Open-market sales · 14,920 sh · avg $44.64 · $666,058 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-06-23 | Option exercise · Stock Option (Right to Buy) | −5,560 | 533,315 | D: show line 5 in the form | |||||
| Virgin Herbert EVP, Research & CSO | 2020-06-24 | Option exercise · Stock Option (Right to Buy) | −9,360 | 523,955 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…